Last reviewed · How we verify

NCT04432519

Multi-level Dimensional Changes at Immediate Implant Sites

Completed NA Last updated 16 June 2020
What this trial tests

NA trial testing Immediate dental implant placement in Dental Implant Failed in 28 participants. Completed in 8 June 2020.

Timeline
1 June 2019
Primary endpoint
8 June 2020
8 June 2020

Quick facts

Lead sponsorUniversidade Católica Portuguesa
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment28
Start date1 June 2019
Primary completion8 June 2020
Estimated completion8 June 2020
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Católica Portuguesa

Who can join

18 and older, any sex, with Dental Implant Failed. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Studies evaluating the use of customized healing screws/abutments in immediate implant placement have been performed, aiming to assess possible advantages with the use of this treatment modality. Despite the existence of these investigations, there is a lack of information regarding a digital approach to evaluate in an objective manner soft and hard tissue dimensional changes at this treatment modality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Immediate dental implant placement

Trials testing the same drug.

Other recruiting trials for Dental Implant Failed

Currently open trials in the same condition.

Other Universidade Católica Portuguesa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04432519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing